Bank Of America Corp Hutchmed (China) LTD Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Bank Of America Corp holds 21,342 shares of HCM stock, worth $404,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,342

Previous 19,980 6.82%

Holding current value

$404,217

Previous $361,000 0.83%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.08 - $18.56 $16,452 - $25,278	1,362 Added 6.82%	21,342 $358,000
Q4 2023 Feb 14, 2024	SELL	$16.25 - $20.23 $588,542 - $732,690	-36,218 Reduced 64.45%	19,980 $361,000
Q2 2023 Aug 14, 2023	SELL	$10.78 - $17.73 $403,118 - $663,013	-37,395 Reduced 39.95%	56,198 $674,000
Q1 2023 May 12, 2023	BUY	$13.02 - $19.87 $923,378 - $1.41 Million	70,920 Added 312.79%	93,593 $1.22 Million
Q4 2022 Feb 10, 2023	SELL	$7.65 - $15.51 $805,070 - $1.63 Million	-105,238 Reduced 82.27%	22,673 $335,000

Q3 2022 Nov 14, 2022	SELL	$8.63 - $15.52 $47,594 - $85,592	-5,515 Reduced 4.13%	127,911 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$8.59 - $20.77 $4.94 Million - $11.9 Million	-574,552 Reduced 81.15%	133,426 $1.69 Million
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $431,595 - $991,390	27,809 Added 4.09%	707,978 $13.4 Million
Q4 2021 Feb 08, 2022	SELL	$28.89 - $35.33 $930,980 - $1.14 Million	-32,225 Reduced 4.52%	680,169 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $4.55 Million - $5.48 Million	127,509 Added 21.8%	712,394 $26.1 Million
Q2 2021 Sep 13, 2021	BUY	$23.7 - $39.27 $13.9 Million - $23 Million	584,885 New	584,885 $23 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

14M

Call Options Held

2.7K

Put Options Held

3.7K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.28B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Hutchmed (China) LTD Transaction History